Research indicates that support staff and organized processes are often insufficient to manage the array of activities required to effectively step through the in-licensing process. Having the appropriate staff and proper procedures to manage in-licensing is necessary to take full advantage of in-licensing opportunities.
Pharmaceutical companies can use this information to evaluate in-licensing processes and organizational structures, perform a gap analysis, and then implement more effective in-licensing management techniques. Based on research of 14 leading pharmaceutical companies, this 41-slide presentation details how organizations conduct in-licensing opportunities, as well as structure and staff in-licensing groups.
- Integrating Critical Capabilities
*One company has consolidated all critical in-licensing management capabilities under the Corporate and Business Development group, which reports directly to the CEO.
- Developing Specializations
*In-licensing activities at one pharmaceutical company are led by two separate yet well-coordinated organizations based on compound stages.
- Managing In-licensing Process *One leading pharmaceutical company maps out every stage and step of the licensing process.
- Dedicated staff conduct scientific, technical and commercial assessments, leading to improved decision quality and speed.
- Alliance management capabilities are built to ensure continued health of in-licensing partnerships.
This information was collected from the Best Practices, LLC Business Excellence Board. It was conducted on behalf of a leading pharmaceutical company based on surveys, interviews and case studies of over 14 benchmark partners from the pharmaceutical and biotechnology industry.